Department of Vaccination and Immune Protection, National Institute for Health and Welfare, Helsinki, Finland.
Clin Infect Dis. 2012 Dec;55(12):1673-6. doi: 10.1093/cid/cis799. Epub 2012 Sep 12.
We reanalyzed the 7-valent pneumococcal conjugate vaccine trial FinOM for prevention of acute otitis media (AOM), with a focus on disease replacement due to other pathogens and AOM recurrence. We found evidence of replacement disease occurring early during the trial follow-up and little vaccine impact on recurrent overall AOM episodes.
我们重新分析了 7 价肺炎球菌结合疫苗试验 FinOM 预防急性中耳炎(AOM)的结果,重点关注因其他病原体引起的疾病替代和 AOM 复发。我们发现试验随访早期出现疾病替代的证据,疫苗对总复发 AOM 发作的影响很小。